A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Although vitamin D supplementation in the frail elderly improves calcium absorption, suppresses parathyroid hormone, decreases bone loss and reduces the risk of fractures, such treatment may be ineffective in patients with vertebral osteoporosis, because of impaired vitamin D metabolism or resistance to the action of vitamin D metabolites on the bowel. We have therefore performed a randomized, single masked study comparing the effects of alfacalcidol treatment (0.25 µg twice daily) and vitamin D2 supplementation (500-1000 units daily) on calcium absorption and bone turnover in 46 elderly women (median age 69 years, range 64–79 years) with radiological evidence of vertebral fractures. Serum 25-hydroxyvitamin D increased significantly after 3 and 6 months of treatment with vitamin D2 (p<0.001), but was unchanged in the group receiving alfacalcidol. Serum 1,25-dihydroxyvitamin D did not change significantly in either group over the study period. Fractional45Ca absorption increased after 3 months of treatment with alfacalcidol (p<0.05), but was unchanged with vitamin D2. There was also a reduction in plasma intact parathyroid hormone and serum alkaline phosphatase after 6 months of treatment with alfacalcidol (p<0.05) which was not seen in the group receiving vitamin D2. Our study shows that vitamin D2 supplementation is ineffective in stimulating calcium absorption in elderly women with vertebral osteoporosis. By increasing calcium absorption in such patients, alfacalcidol may prove more effective than vitamin D in the management of vertebral osteoporosis.
- Bullamore Jr, Gallagher JC, Wilkinson R, Nordin BEC, Marshall DH. Effect of age on calcium absorption. Lancet 1970;2:535–7.
- Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 1979;64:729–36.
- Baker MR, Peacock M, Nordin BEC. The decline in vitamin D status with age. Age Ageing 1980;9:249–52.
- Khaw KT, Sneyd MJ, Compston J. Bone density parathyroid hormone and 25-hydroxvitamin D concentrations in middle aged women. BMJ 1992;305:273–7.
- Francis RM, Peacock M, Storer JH, Davies AEJ, Brown WB, Nordin BEC. Calcium malabsorption in the elderly: the effect of treatment with oral 25 hydroxyvitamin D3. Eur J Clin Invest 1983;13:391–6.
- Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505–12.
- Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–42.
- Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105–10.
- Gallagher JC, Aaron J, Horsman A, Marshall DH, Wilkinson R, Nordin BEC. The crush fracture syndrome in postmenopausal women. Clin Endocrinol Metab 1973;2:293–315.
- Slovick DM, Adams JS, Neer RM, Holick MF, Potts JT. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 1981;305:372–4.
- Francis RM, Peacock M, Taylor GA, Storer JH, Nordin BEC. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci 1984;66:103–7.
- Francis RM, Peacock M. Local action of oral 1,25-dihydroxy-cholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr 1987;46:315–8.
- Francis RM, Robinson CJ, Davison CE, Rodgers A. The short term effects of alfacalcidol in elderly osteoporotic women. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath Dv, editors. Vitamin D: molecular, cellular and clinical Endocrinology. Berlin: Walter de Gruyter, 1988:846–7.
- Cohen HN, Farrah D, Fogelman I, et al. A low dose regime of 1α-hydroxyvitamin D in the management of senile osteoporosis: a pilot study. Clin Endocrinol 1980;12:537–42.
- Peacock M. Osteomalacia. In: Nordin BEC, editor. Metabolic bone and stone disease, 2nd ed. Edinburgh: Churchill Livingstone, 1984:71–111.
- Nelson M, Hague GF, Cooper C, Bunker VW. Calcium intake in the elderly: validation of a dietary questionnaire. J Hum Nutr Diet 1988;1:115–27.
- Preece MA, O'Riordan JLH, Lawson DEM, Kodicek E. A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-ergocalciferol in serum. Clin Chim Acta 1974;54:235–42.
- Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography. J Clin Endocrinol Metab 1984;58:91–8.
- Logue FC, Perry B, Chapman RS, Milne I, James K, Beastall GH. A two-site immunoradiometric assay for PTH (1–84) using N and C terminal specific monoclonal antibodies. Ann Clin Biochem 1991;28:160–6.
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine Nephron 1976;16:31–41.
- Nordin BEC, Need AG, Morris HA, Horowitz M. The rationale for calcitriol therapy in osteoporosis. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath Dv, editors. Vitamin D: molecular, cellular and clinical Endocrinology. Berlin: Walter de Gruyter, 1988:826–35.
- Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. The effect of vitamin D supplementation on the incidence of hip fractures in elderly people. J Bone Miner Res 1994;9(Suppl 1):S148, abstr 112
- Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986;1:407–13.
- Nordin BEC, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985;42:470–4.
- Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284–7.
- Francis RM, Peacock M, Barkworth SA. Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 1984;13:14–20.
- Hamdy NAT, Kanis JA, Beneton MNC, et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 1995;310:358–63.
- Riggs BL. Calcitriol in the treatment of osteoporosis. In: Christiansen C, Riis B. editors. Proceedings of the Fourth International Symposium on Osteoporosis, Rodovre, Denmark, 1993:528–30.
- Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357–62.
- Orimo H, Shiraki M, Hayashi Y, et al. Effects of 1α-hydroxy-vitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994;54:370–6.
- A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures
Volume 6, Issue 4 , pp 284-290
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Calcium absorption
- Vertebral fractures
- Vitamin D2
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine (Geriatrics), University of Newcastle upon Tyne, Newcastle General Hospital, Newcastle upon Tyne
- 3. University Departments of Medicine and Pathological Biochemistry, Royal Infirmary, Glasgow
- 4. Department of Clinical Biochemistry, Kings College Hospital, London
- 5. Medical Department, Leo Laboratories Limited, Princes Risborough, UK